CA-ANDERSEN-GLOBAL
Efter den hurtige udvidelse i Afrika forener Andersen Global nu sine afrikanske medlemsfirmaer under brandet ”Andersen”. Som en del af denne overgang vil fem tidligere samarbejdspartnere blive medlemsfirmaer af Andersen Global, hvorved platformen i Afrika styrkes. Offentliggørelsen følger i hælene på implementeringen af Andersen-brandet af det stiftende amerikanske medlemsfirma i 2019 og medlemsfirmaer i Europa, Latinamerika og Mellemøsten i 2020.
Andersen Global-medlemsfirmaer i Nigeria og Kenya, som tidligere opererede under brandet ”Andersen Tax”, vil nu overgå til det kendte brand ”Andersen”. Tidligere samarbejdspartnere i Sydafrika (Tabacks), Tunesien (Jelil Bouraoui & Associates) samt Mauritius og Seychellerne (ATax Advisors) vil ligeledes implementere det nye Andersen-brand. Andersen Global byder også medlemsfirmaer på Elfenbenskysten (Mondon Conseil) og i Mozambique (Isálcio Mahanjane Advogado & Associados) velkommen.
At arbejde under et kendt brand demonstrerer regionens evne til at tilbyde ukomplicerede tjenester globalt sammen med de andre Andersen Global-medlemsfirmaer. Andersen Global er via sine medlemsfirmaer og samarbejdspartnere repræsenteret i 45 lande på kontinentet, indbefattet juridiske tjenester i 41 lande.
”I de sidste mange år har vores platform i Afrika haft en høj prioritet i overensstemmelse med vores forpligtelse over for kundeservice og tilvejebringelsen af ukomplicerede skatte- og juridiske tjenester globalt. Efterhånden som økonomien og markederne fortsætter med at ændre sig og blive mere globale, er vores organisations behov for omfattende løsninger på tværs af landegrænser blevet vigtigere. Igennem vores udvidelsesbestræbelser og foreningen af vores afrikanske medlemsfirmaer under et kendt brand, har vi opnået vores mål om at have det største juridiske fodaftryk på kontinentet” udtalte Mark Vorsatz, Andersen Global bestyrelsesformand og adm. direktør hos Andersen. ”Vi forbliver forpligtet over for at være et af de mest betydningsfulde skatte- og advokatfirmaer når det gælder medarbejderstab, geografisk dækning og – vigtigst af alt – kvalitet”.
For yderligere at styrke sin ledelsesstruktur i regionen, har organisationens afrikanske bestyrelse valgt Jelil Bouraoui som virksomhedsleder hos Andersen i Tunesien til at repræsentere regionen i bestyrelsen hos Andersen Global. Derudover vil Olaleye Adebiyi, virksomhedsleder hos Andersen i Nigeria, og Derrick Kaufmann, virksomhedsleder hos Andersen i Sydafrika, tjene som assisterende virksomhedsledere i regionen. Jelil, Olaleye og Derrick vil arbejde tæt sammen for at administrere organisationen i Afrika og støtte regionens fremtidige udvidelsesbestræbelser.
Grundlaget for Andersens globale platform går helt tilbage til 2002, hvor 23 tidligere Arthur Andersen-partnere oprettede et firma, der kun beskæftigede sig med skat, WTAS LLC, som efterfulgtes af Andersen Global (tidligere WTAS Global) i 2013. Det efterfølgende år tog det amerikanske medlemsfirma brandet ”Andersen Tax” til sig, efterfulgt af medlemsfirmaer i Latinamerika, Europa og Afrika. Andersen Tax debuterede i Nigeria i 2017 og i Kenya i 2018, og regionen er siden blevet udvidet til i dag at omfatte mere end 65 lokationer, 1.000 medarbejdere inden for skat og jura og næsten 200 partnere.
I løbet af det næste år fortsætter medlemsfirmaer i Canada og Israel med at implementere det fælles Andersen-brand, mens Andersen Global fortsætter med at udvide på vigtige markeder, herunder Caribien, Latinamerika, Afrika og Mellemøsten.
Andersen Global er en international sammenslutning af juridisk adskilte, uafhængige medlemsfirmaer bestående af skatte- og juraeksperter fra hele verden. Efter at være blevet etableret i 2013 af det amerikanske medlemsfirma Andersen Tax LLC har Andersen Global nu over 7.000 eksperter globalt og er repræsenteret på mere end 254 lokaliteter via sine medlems- og samarbejdsfirmaer.
Originalsprogsudgaven af denne bekendtgørelse er den officielle, autoriserede version. Oversættelserne er kun tænkt som en hjælp og bør sammenholdes med kildesprogsteksten, der som den eneste er juridisk bindende.
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20210224005456/da/
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
CoMotion GLOBAL 2025 Launches in Riyadh: Global Mobility Leaders Unite in Saudi Capital to Chart Urban Future7.12.2025 13:00:00 CET | Press release
Summit debuts Mayors in Motion initiative and CoMotion Urban Visionary Distinction as Riyadh showcases its rise as global mobility testbed Riyadh is rapidly becoming one of the world's most ambitious urban mobility laboratories, where next-generation technologies move from blueprint to real-world deployment on city streets at unprecedented scale. CoMotion GLOBAL 2025, the world's most influential gathering of urban mobility leaders, opens today in Riyadh for a three-day summit bringing together innovators from Africa, Asia, Europe, the Americas, and the Middle East. Running December 7-9, the event will explore how electrification, autonomy, AI-enabled transport, and giga-project urbanism are reshaping cities worldwide. The summit will spotlight everything from high-performance EVs and breakthrough autonomous fleets to emerging-market transport solutions and new mobility models, demonstrating how the Kingdom is opening new pathways for global mobility leadership. Strategic Partnerships
Deciphera Announces Oral Presentation of Positive Topline Results from Phase 2a Study of Sapablursen in Polycythemia Vera at the 67th American Society of Hematology (ASH) Annual Meeting6.12.2025 15:30:00 CET | Press release
Results from Phase 2a IMPRSSION study demonstrate sapablursen significantly reduced phlebotomy rate, controlled hematocrit and increased serum hepcidin Sapablursen was generally safe and well tolerated Results support further development of sapablursen in a Phase 3 study Deciphera Pharmaceuticals, a member of Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”), today announced the oral presentation of positive results from the Phase 2a IMPRSSION study of sapablursen in patients with polycythemia vera (PV) at the 67th American Society of Hematology (ASH) Annual Meeting, taking place December 6-9, 2025, in Orlando, FL. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251206361611/en/ The results were presented by Ionis Pharmaceuticals, who discovered and developed sapablursen and conducted the IMPRSSION study. In March 2025, Ionis and Ono entered into a license agreement in which On
Protagonist and Takeda Present Longer-Term Data at ASH 2025 Showing Rusfertide Delivers Durable Response and Hematocrit Control in Polycythemia Vera6.12.2025 15:30:00 CET | Press release
52-Week Results from the Phase 3 VERIFY Study of Rusfertide Demonstrated Sustained Hematocrit Control and Response, Defined by Absence of Phlebotomy Eligibility, with No New Safety SignalsThese Data Build on Positive 32-Week Primary Analysis from VERIFY, Which Met its Primary Efficacy Endpoint and All Four Key Secondary EndpointsPatients Crossing Over from Placebo to Rusfertide at 32 Weeks Achieved a Similar Response Rate to Those Initially Randomized to Rusfertide, with 77.9% Achieving Absence of Phlebotomy Eligibility Between Weeks 40-52Four-Year Results from the Combined REVIVE and Long-Term Extension THRIVE Study Demonstrated a 13-Fold Reduction in Annual Rate of Phlebotomies from Baseline Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) announce that new 52-week results from the pivotal Phase 3 VERIFY study evaluating rusfertide in patients with polycythemia vera (PV) will be presented in an oral presentation at the 67th American Society
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions6.12.2025 13:01:00 CET | Press release
- Data from pivotal studies of CASGEVY in children ages 5-11 years with severe sickle cell disease or transfusion-dependent beta thalassemia demonstrates the transformative potential of the therapy in younger patients -- Efficacy and safety data in children 5-11 years are consistent with the durable and positive benefit/risk profile established from clinical studies in patients 12 years of age and older -- Vertex expects to initiate global regulatory submissions for CASGEVY in children 5-11 years in 1H 2026 - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data from multiple studies demonstrating the clinical benefits of CASGEVY® (exagamglogene autotemcel) in people ages 5 years and older living with severe sickle cell disease (SCD) or transfusion-dependent beta thalassemia (TDT). The results, including the first presentation of clinical data from pivotal studies in children ages 5-11 years, and longer-term data from the pivotal studies of people with severe SCD and
Leading Global Scientists Gather at Tengchong Scientists Forum to Explore Innovative Pathways in Frontier Technologies6.12.2025 12:31:00 CET | Press release
The 2025 Tengchong Scientists Forum opened on Saturday in southwest China’s Yunnan Province, convening leading scientists and academic figures to examine innovation across frontier fields including artificial intelligence, biodiversity and quantum technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251205499197/en/ Opening ceremony of Tengchong Scientists Forum on 6th December, 2025 Notable participants include Nobel Physics laureate Konstantin Novoselov, Fields Medalist Efim Zelmanov and Turing Award winner Andrew Chi-Chih Yao, who join 127 academicians, 77 university presidents from China and abroad, over 400 scholars and more than 600 entrepreneurs and financiers. The gathering aims to deepen collaboration between cutting-edge research and industrial development. Under the theme “Science · AI changing the World,” the forum features ten sub-forums, academic sessions and thematic events supporting major cooperation p
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum